Quick Links

Drug Research

Project Information

Bill and Melinda Gates Foundation funded project for antiparasitic drug discover in Africa; co-funded by Grand Challenges Canada and CIHR.

Project Date: 
01/01/2011 to 10/27/2022
Type of Project: 
Research Area: 
Health Research
Sub-Research Area: 
Drug research
Funding Source: 
Grand Challenges Canada
The Bill & Melinda Gates Foundation
United States
South Africa
McGill University Project Leader Information
Project Leader: 

Timothy Geary

Profile Picture: 
Primary Position
Faculty of Medicine
Pharmacology & Therapeutics
Institute of Parasitology
Other Position/Appointment: 
Director, Institute of Parasitology
Research Interests: 
Coming from a 20-year career in the pharmaceutical industry, I have a strong background in drug discovery and in all aspects of the pharmacology of antiparasitic drugs. This work includs the molecular identification of drug targets through functional genomic analysis of helminth physiology and the engineering of recombinant systems for high-throughput screening for new antiparasitic leads. My lab does research on drug targets in parasites and on the chemotherapy of antiparasitic drugs. In addition, my interests include basic work on the proteins secreted by parasites and hosts that determine the success of infection. Proteomic analysis of the ‘secretome’ of filarial parasites, and the manner in which drugs such as ivermectin affect the secretome, is a focus of my research. This program encompasses both protozoal parasites of human and veterinary importance and includes international collaborators. I am currently looking for students to join my laboratory.
Principal Investigator
Other McGill Contacts
McGill Contact: 
Eliane Ubalijoro